To measure the concentration of potentially harmful toxic heavy metals in the blood and brain fluid of patients with ALS (amyotrophic lateral sclerosis)- a lethal neurological illness – a cross-sectionalstudy
Not Applicable
- Conditions
- Health Condition 1: G122- Motor neuron disease
- Registration Number
- CTRI/2024/01/061645
- Lead Sponsor
- Institute Research Grant AIIMS BBSR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Probable or Definite ALS
Exclusion Criteria
Patients where CSF cannot be done
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimation of Plasma and CSF levels of heavy metals in patients with ALS (amyotrophic lateral sclerosis).Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method Comparison of CSF levels with plasma levels of heavy metals in patients with ALSTimepoint: 12 months